Terns Pharmaceuticals Inc. (TERN)
52.95
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 15-12G Terns Pharmaceuticals,
May 15, 2026 9:01 AM - SEC Filing
Form SCHEDULE 13G/A Terns Pharmaceuticals, Filed by: Adage Capital Management, L.P.
May 13, 2026 9:19 AM - SEC Filing
Form SCHEDULE 13G/A Terns Pharmaceuticals, Filed by: MORGAN STANLEY
May 12, 2026 11:11 AM - SEC Filing
Form EFFECT Terns Pharmaceuticals,
May 8, 2026 6:09 AM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: Azelby Robert
May 5, 2026 5:08 PM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: Turner Heather D
May 5, 2026 5:07 PM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: Tripuraneni Radhika
May 5, 2026 5:06 PM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: Quigley Jill M.
May 5, 2026 5:05 PM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: KINDLER JEFFREY B
May 5, 2026 5:04 PM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: FELLOWS DAVID A
May 5, 2026 5:03 PM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: Kuriakose Emil
May 5, 2026 5:02 PM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: Gengos Andrew
May 5, 2026 5:01 PM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: Burroughs Amy L.
May 5, 2026 5:00 PM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 10:10 AM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 10:07 AM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 10:05 AM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 10:03 AM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 10:01 AM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 9:58 AM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 9:56 AM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 9:54 AM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 9:51 AM - SEC Filing
Form POS AM Terns Pharmaceuticals,
May 5, 2026 9:47 AM - SEC Filing
Form POSASR Terns Pharmaceuticals,
May 5, 2026 9:44 AM - SEC Filing
Form 8-K Terns Pharmaceuticals, For: May 05
May 5, 2026 9:22 AM - SEC Filing
Form SC 14D9/A Terns Pharmaceuticals, Filed by: Terns Pharmaceuticals, Inc.
May 5, 2026 9:16 AM - SEC Filing
Form 25-NSE Terns Pharmaceuticals, Filed by: Nasdaq Stock Market LLC
May 5, 2026 8:57 AM - SEC Filing
Form SC TO-T/A Terns Pharmaceuticals, Filed by: Merck & Co., Inc.
May 5, 2026 8:53 AM - SEC Filing
Merck completes $5.8 billion acquisition of Terns Pharmaceuticals
May 5, 2026 8:45 AM - StreetInsider
Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
May 5, 2026 8:45 AM - BizWire
Form 10-K/A Terns Pharmaceuticals, For: Dec 31
April 27, 2026 4:19 PM - SEC Filing
Form 8-K Terns Pharmaceuticals, For: Apr 27
April 27, 2026 8:10 AM - SEC Filing
Terns Pharmaceuticals receives FDA breakthrough designation for TERN-701
April 27, 2026 8:05 AM - StreetInsider
Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia
April 27, 2026 8:05 AM - Globe NewsWire
Oppenheimer Downgrades Terns Pharmaceuticals (TERN) to Perform
April 27, 2026 12:55 AM - StreetInsider
Form SC 14D9/A Terns Pharmaceuticals, Filed by: Terns Pharmaceuticals, Inc.
April 24, 2026 8:11 AM - SEC Filing
Form SC TO-T/A Terns Pharmaceuticals, Filed by: Merck & Co., Inc.
April 24, 2026 7:31 AM - SEC Filing
Merck clears HSR waiting period for $53 per share Terns acquisition
April 24, 2026 6:45 AM - StreetInsider
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
April 24, 2026 6:45 AM - BizWire
Full Article List
